Reporting owner · CIK 0002123975

Sahin Ugur

SEC Form 4 history across 1 companies, 26 transactions and 14 filings.

CEOChief Executive OfficerBioNTech SE
Open-market transaction mix0% buys0 buys · 26 sales

Available history · Sep 03, 2026 – Oct 09, 2026

Filings14Form 4 records
Buying$00 purchases
Selling$84.2M26 sales
Net value−$84.2MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Sahin Ugur transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.45MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$2.49MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$2.30MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$2.03MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$7.00MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$1.64MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$1.65MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.13MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.34MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.34MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$2.66MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.86MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$2.98MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$4.63MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.22MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$2.88MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.35MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$1.44MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$3.28MView disclosure →
BNTXBioNTech SE
Sahin UgurCEOS · sale10b5-1 detectedSEC filing ↗-$4.07MView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at BioNTech SE on Oct 09, 2026 valued at $3,453,372.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 2026019$0.00$63,651,046.65-$63,651,046.65
Oct 202607$0.00$20,581,198.22-$20,581,198.22

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$3.2M
Median P/S size$3.3M
Direct26
Indirect0
Oct 09, 2026sale

Associated companies

Companies in the disclosed reporting history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

26 observations · Sep 3, 2026 – Oct 9, 2026. Window ends at the latest available report, not today.

Selected observation · Oct 9, 20260 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 3, 2026813,209Sep 8, 2026View transaction
Sep 4, 2026781,709Sep 8, 2026View transaction
Sep 8, 2026744,709Sep 9, 2026View transaction
Sep 9, 2026708,709Sep 9, 2026View transaction
Sep 10, 2026688,209Sep 11, 2026View transaction
Sep 11, 2026643,209Sep 14, 2026View transaction
Sep 14, 2026602,209Sep 14, 2026View transaction
Sep 15, 2026568,209Sep 16, 2026View transaction
Sep 16, 2026553,209Sep 16, 2026View transaction
Sep 17, 2026519,209Sep 18, 2026View transaction
Sep 18, 2026489,209Sep 18, 2026View transaction
Sep 21, 2026456,209Sep 22, 2026View transaction
Sep 22, 2026410,209Sep 22, 2026View transaction
Sep 23, 2026380,209Sep 24, 2026View transaction
Sep 24, 2026341,209Sep 24, 2026View transaction
Sep 25, 2026314,209Sep 28, 2026View transaction
Sep 28, 2026280,209Sep 28, 2026View transaction
Sep 29, 2026246,209Sep 30, 2026View transaction
Sep 30, 2026214,209Sep 30, 2026View transaction
Oct 1, 2026197,209Oct 2, 2026View transaction
Oct 2, 2026180,209Oct 2, 2026View transaction
Oct 5, 2026108,209Oct 6, 2026View transaction
Oct 6, 202687,209Oct 6, 2026View transaction
Oct 7, 202663,209Oct 7, 2026View transaction
Oct 8, 202636,209Oct 9, 2026View transaction
Oct 9, 20260Oct 9, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Sahin Ugur Insider Activity FAQ

SEC Form 4 context

Who is Sahin Ugur?

Sahin Ugur is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002123975.

Which companies has Sahin Ugur reported transactions for?

BioNTech SE

When was Sahin Ugur's latest insider buy?

No open-market insider purchase is available for this period.

When was Sahin Ugur's latest insider sale?

sale at BioNTech SE on Oct 09, 2026 valued at $3,453,372.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.